Bortezomib-Based Regimens Used As Induction In Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible For Stem Cell Transplantation (Sct)The Cost-Utility Analysis
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1340
https://www.valueinhealthjournal.com/article/S1098-3015(14)01391-6/fulltext
Title :
Bortezomib-Based Regimens Used As Induction In Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible For Stem Cell Transplantation (Sct)The Cost-Utility Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01391-6&doi=10.1016/j.jval.2014.03.1340
First page :
A229
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
806